For citations:
Ananyeva L.P., Garzanova L.A., Desinova O.V., Shayakhmetova R.U., Starovoytova M.N., Koneva O.A., Ovsyannikova O.B., Glukhova S.I., Nasonov E.L. The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis. Rheumatology Science and Practice. 2023;61(4):485-492. (In Russ.) https://doi.org/10.47360/1995-4484-2023-485-492
Email this article 